Document is current
Any future updates will be listed below
-
Authors
Kilduff, Stella https://orcid.org/0000-0001-8645-959X
Hayde, Nicole
Viswanathan, Shankar
Reidy, Kimberly
Abramowitz, Matthew K.
-
Funding
Funding for this research was provided by:
NIH/National Center for Advancing Translational Sciences (UL1TR00107)
New York Consortium for Interdisciplinary Training on Kidney, Urological and Hematological Research (TL1DK136048)
National Institutes of Health (R01DK131811, R01DK131176)
- License Information
-
More Information
Article History
Received: 23 January 2023
Revised: 22 June 2023
Accepted: 22 June 2023
First Online: 8 July 2023
Declarations
:
: The study was approved by the institutional review board for Montefiore Medical Center / Albert Einstein College of Medicine (IRB Number: 2021–13548).
: The need for informed consent was waived due to the use of de-identified data.
: Stella Kilduff has grant funding by TL1DK136048 and UL1TR001073. Author Kimberly Reidy has grants supported by R01DK131811 and R01DK131176. Dr. Kimberly Reidy is also a site investigator for Advicienne and Travere Therapeutics funded clinical trials that are unrelated to this manuscript. Authors Stella Kilduff, Nicole Hayde, Shankar Viswanathan, and Matthew Abramowitz declare that they have no conflicts of interest or disclosures.
